Company Search:
Advanced Search
Sponsored Links
Seoulin Bioscience Company Limited Company Snapshot
Seoulin Bioscience Company Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Seoulin Bioscience Company Limited with three other companies in this sector in South Korea: NanoenTek Incorporated (2016 sales of 22.21 billion Korean Won [US$20.85 million] of which 52% was Biotechnology), Bioneer Corporation (21.70 billion Korean Won [US$20.38 million] ), and Medipost Co Ltd (28.65 billion Korean Won [US$26.91 million] of which 55% was Umbilical Cord Blood).

Sales Analysis. During the year ended December of 2016, sales at Seoulin Bioscience Company Limited were 44.89 billion Korean Won (US$42.15 million). This is an increase of 7.8% versus 2015, when the company's sales were 41.63 billion Korean Won. Sales of Healthcare saw an increase that was more than double the company's growth rate: sales were up 112.2% in 2016, from 1.17 billion Korean Won to 2.49 billion Korean Won.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Seoulin Bioscience Company Limited
  Stock Performance Chart for Seoulin Bioscience Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 13,550
(Figures in Korean Won)
1 Week 2.7%   13 Weeks 0.4%  
4 Weeks 13.3%   52 Weeks 13.8%  
Seoulin Bioscience Company Limited Key Data:
  Ticker: 038070 Country: Korea (South)
  Exchanges: SEO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 44,889,258,133
(Year Ending Jan 2017).
Employees: 91
  Currency: Korean Won Market Cap: 92,724,343,236
  Fiscal Yr Ends: December Shares Outstanding: 6,843,125
  Share Type: Common Closely Held Shares: 2,118,654
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.